Stay updated on Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP.
Sign up to get notified when there's something new on the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page.

Latest updates to the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe clinical trial record for oral QLT091001 in people with RPE65-related retinitis pigmentosa is displayed, with study details and historical record information.SummaryDifference35%

- Check16 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0, while the study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA site-wide NIH banner was added above the ClinicalTrials.gov page, linking to transition updates and noting the agency’s shift from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov error page now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer's site revision number changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page was updated to revision v3.7.0, with removal of several legacy UI labels and historical data sections, resulting in a streamlined study record view.SummaryDifference15%

Stay in the know with updates to Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP.
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: QLT091001 in Autosomal Dominant RPE65 RP. page.